# Glaxo Wellcome Manufacturing Pte Limited - Inspection Records

Source: https://www.keypedia.com/companies/glaxo-wellcome-manufacturing-pte-limited/5bc5ffcf-9696-4708-86c1-f63fb5a0fc28

> Inspection records and compliance data for Glaxo Wellcome Manufacturing Pte Limited in Singapore, None. Access full analysis and detailed observations.

---

## Details

- Name: Glaxo Wellcome Manufacturing Pte Limited
- FEI Number: 3002807079
- City: Singapore
- State: None
- Country Name: Singapore
- Address Line 1: Pioneer Sector 1
- Zip Code: None

## Related Documents

- [FDA Inspection 1275331 - Glaxo Wellcome Manufacturing Pte Limited - 2023-10-13](https://www.keypedia.com/records/fda_inspections/glaxo-wellcome-manufacturing-pte-limited/8cbb5aba-d1c2-41d9-a13b-4c75ff538297) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 13, 2023
- [FDA Inspection 1191253 - Glaxo Wellcome Manufacturing Pte Limited - 2022-09-02](https://www.keypedia.com/records/fda_inspections/glaxo-wellcome-manufacturing-pte-limited/4b957da9-8c89-41eb-963a-056f21d9dc0b) — classification: No Action Indicated (NAI), source: FDA, date: September 2, 2022
- [FDA Inspection 1055375 - Glaxo Wellcome Manufacturing Pte Limited - 2018-06-01](https://www.keypedia.com/records/fda_inspections/glaxo-wellcome-manufacturing-pte-limited/bb19f612-9f12-414c-b441-03e54b595aa4) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 1, 2018
- [FDA Inspection 865559 - Glaxo Wellcome Manufacturing Pte Limited - 2014-01-16](https://www.keypedia.com/records/fda_inspections/glaxo-wellcome-manufacturing-pte-limited/e90c7c12-5998-4d12-a365-18a1ea4a52eb) — classification: No Action Indicated (NAI), source: FDA, date: January 16, 2014
- [FDA Inspection 807638 - Glaxo Wellcome Manufacturing Pte Limited - 2012-11-16](https://www.keypedia.com/records/fda_inspections/glaxo-wellcome-manufacturing-pte-limited/849162d6-7817-4728-99ca-6e47894e61bd) — classification: No Action Indicated (NAI), source: FDA, date: November 16, 2012
- [FDA Inspection 572094 - Glaxo Wellcome Manufacturing Pte Limited - 2009-03-13](https://www.keypedia.com/records/fda_inspections/glaxo-wellcome-manufacturing-pte-limited/8515a833-ea66-4963-a018-37e5b0ed757d) — classification: No Action Indicated (NAI), source: FDA, date: March 13, 2009

## Related Companies

- [Curia Missouri Inc](https://www.keypedia.com/companies/curia-missouri-inc/06aae102-a562-47fe-be57-6fd281db48f4)
- [Curia Spain SAU](https://www.keypedia.com/companies/curia-spain-sau/a097eb87-d69b-4eee-81f1-0a54db9adea5)
- [Curia Wisconsin, Inc.](https://www.keypedia.com/companies/curia-wisconsin-inc/dfb0170c-c415-44a7-80c0-85657c02a581)
- [Sterling Wisconsin, LLC](https://www.keypedia.com/companies/sterling-wisconsin-llc/1bef3270-1910-4a5c-bef6-4d3cb443a44d)
- [Micro-Macinazione SA](https://www.keypedia.com/companies/micro-macinazione-sa/6f144812-4586-4004-8345-e0250ba95667)
- [Curia New York, Inc.](https://www.keypedia.com/companies/curia-new-york-inc/af5afa88-d7a2-4f74-a387-edbcf6a6e666)
- [Novartis Pharma Schweizerhalle Ag](https://www.keypedia.com/companies/novartis-pharma-schweizerhalle-ag/98c70c71-2e4d-4ca3-9db3-d7582815b731)
- [Evonik Corporation](https://www.keypedia.com/companies/evonik-corporation/5f1fa8da-b68a-4d31-bbfa-2aba62e8a4d1)
- [Pharmacia Hepar, LLC](https://www.keypedia.com/companies/pharmacia-hepar-llc/91f6a86c-a9c8-4fb9-9931-2207715a1afc)
- [BioSpectra, Inc.](https://www.keypedia.com/companies/biospectra-inc/ffb13a38-4f04-49cb-a6fe-fd55f544fcf0)